Similar articles for PMID: 21885500

Year	Number of Results
1976	1
1987	1
1994	2
1995	3
1996	3
1997	2
1998	2
1999	3
2000	2
2001	2
2002	10
2003	12
2004	4
2005	13
2006	14
2007	11
2008	15
2009	16
2010	13
2011	16
2012	40
2013	26
2014	30
2015	29
2016	23
2017	13
2018	13
2019	11
2020	15
2021	15
2022	15
2023	6
2024	0

1

Levels of serum matrix metalloproteinase-3 correlate with disease activity in the enthesitis-related arthritis category of juvenile idiopathic arthritis.

Viswanath V, Myles A, Dayal R, Aggarwal A. Viswanath V, et al. J Rheumatol. 2011 Nov;38(11):2482-7. doi: 10.3899/jrheum.110352. Epub 2011 Sep 1. J Rheumatol. 2011. PMID: 21885500

2

Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study.

Peake NJ, Khawaja K, Myers A, Jones D, Cawston TE, Rowan AD, Foster HE. Peake NJ, et al. Rheumatology (Oxford). 2005 Nov;44(11):1383-9. doi: 10.1093/rheumatology/kei025. Epub 2005 Jul 27. Rheumatology (Oxford). 2005. PMID: 16049050

3

Soluble receptor for advanced glycation endproducts is decreased in patients with juvenile idiopathic arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels.

Myles A, Viswanath V, Singh YP, Aggarwal A. Myles A, et al. J Rheumatol. 2011 Sep;38(9):1994-9. doi: 10.3899/jrheum.110058. Epub 2011 Jul 1. J Rheumatol. 2011. PMID: 21724696

4

[Effects of infliximab and etanercept, two types of anti-tumor necrosis factor-alpha inhibitor on serum level of matrix metalloproteinase 3 expression in patients with ankylosing spondylitis].

Yang CH, Huang F, Deng XH, Zhang JL, Zhang LY, Guo JH, Liang DF, Wang LS, Zhang YM. Yang CH, et al. Zhonghua Yi Xue Za Zhi. 2006 Sep 19;86(35):2451-4. Zhonghua Yi Xue Za Zhi. 2006. PMID: 17156669 Chinese.

5

Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.

Keyszer G, Lambiri I, Nagel R, Keysser C, Keysser M, Gromnica-Ihle E, Franz J, Burmester GR, Jung K. Keyszer G, et al. J Rheumatol. 1999 Feb;26(2):251-8. J Rheumatol. 1999. PMID: 9972954

6

Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.

Chen CH, Lin KC, Yu DT, Yang C, Huang F, Chen HA, Liang TH, Liao HT, Tsai CY, Wei JC, Chou CT. Chen CH, et al. Rheumatology (Oxford). 2006 Apr;45(4):414-20. doi: 10.1093/rheumatology/kei208. Epub 2005 Nov 15. Rheumatology (Oxford). 2006. PMID: 16287916

7

Tenascin-C Levels, A Toll-like Receptor 4 Ligand, in Enthesitis-related Arthritis Category of Juvenile Idiopathic Arthritis: A Cross-sectional and Longitudinal Study.

Shukla A, Gaur P, Aggarwal A. Shukla A, et al. J Rheumatol. 2015 May;42(5):891-6. doi: 10.3899/jrheum.141365. Epub 2015 Mar 15. J Rheumatol. 2015. PMID: 25774061

8

Elevated serum receptor activator of NFkappaB ligand (RANKL), osteoprotegerin (OPG), matrix metalloproteinase (MMP)3, and ProMMP1 in patients with juvenile idiopathic arthritis.

Sarma PK, Misra R, Aggarwal A. Sarma PK, et al. Clin Rheumatol. 2008 Mar;27(3):289-94. doi: 10.1007/s10067-007-0701-3. Epub 2007 Aug 17. Clin Rheumatol. 2008. PMID: 17703334

9

Serum and synovial fluid concentrations of matrix metalloproteinases 3 and its tissue inhibitor 1 in juvenile idiopathic arthritides.

Gattorno M, Vignola S, Falcini F, Sabatini F, Buoncompagni A, Simonini G, Picco P, Pistoia V. Gattorno M, et al. J Rheumatol. 2002 Apr;29(4):826-31. J Rheumatol. 2002. PMID: 11950028

10

Serum matrix metalloproteinase 3 levels during treatment with sulfasalazine or combination of methotrexate and sulfasalazine in patients with early rheumatoid arthritis.

Posthumus MD, Limburg PC, Westra J, van Leeuwen MA, van Rijswijk MH. Posthumus MD, et al. J Rheumatol. 2002 May;29(5):883-9. J Rheumatol. 2002. PMID: 12022344 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

320 results

Results by year